Tech Company Financing Transactions
scPharmaceuticals Funding Round
scPharmaceuticals closed a $45.6 million Series B funding round on 1/5/2017. Investors included OrbiMed, 5AM Ventures and Lundbeckfond Ventures.
Transaction Overview
Company Name
Announced On
1/5/2017
Transaction Type
Venture Equity
Amount
$45,600,000
Round
Series B
Investors
Proceeds Purpose
This Series B investment will support the development of the operational and commercial infrastructure to bring Furoscix� and the sc2Wear� Infusor to market in the United States.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2400 District Ave. 310
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
scPharmaceticals (NASDAQ: SCPH) is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two component delivery system suitable for patient self-administration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Tucker
Chief Financial Officer
Troy Ignelzi
Chief Operating Officer
Abraham Ceesay
Browse more venture capital transactions:
Prev: 1/5/2017: Seworks venture capital transaction
Next: 1/5/2017: Tracx venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs